Ophthall Q-Supine ND:YAG Laser

Extreme Ophthall Q-Supine ND:YAG Laser

UNIQUE NEW SUPINE YAG LASER FOR THE TREATMENT OF GERIATRIC AND PAEDIATRIC PATIENTS UNABLE TO SIT AT A SLIT LAMP

  • Unique fully integrated ophthalmic Nd:YAG Laser for supine use
  • Easy to use interface 
  • User friendly for paediatric and disabled patients

Technical Specifications

Device Extreme OPHTHALL Q-SUPINE
Laser source Q-switched Nd:YAG
Wavelength 1064 nm
Energy range 0.3 to 12 mJ (in single pulse mode), 36 mJ max (in triple pulse mode)
Pulse width 4 ns (typical)
Treatment spot size < 10 μm
Burst mode 1,2 or 3 pulses; selectable
Cone angle 16°
Treatment beam offset range Anterior and posterior: 0 to ± 300 μm
Slit lamp CSO 9800 LED Zeiss type
Laser repetition rate 0.5 to 4 Hz
Aiming beam Red Dual Diode; 635 nm
Triggering Joystick (footswitch optional)
Magnification Integrated 3-position: 10x, 16x, 25x (5x optional)
Cooling system Air convection
Dimensions 118 cm (H) x 119.6 cm (W) x 70.6 cm (D) 47 in (H) x 47 in (W) x 28 in (D)
Weight 65 kg /143 lbs.
Power requirements 220 – 240 VAC 50/60 Hz
Power rating 520 VA
Patient position supine

Product specifications are subject to change without notice. Extreme devices are made strictly in accordance with the international laser safety standards: EN 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2.

 

Standard Accessories

  • Laser safety sign
  • Safety glasses
  • Dust cover

Optional Accessories

  • Footswitch
  • 5-position magnifi cation changer
  • Iridotomy lens
  • Capsulotomy lens
  • Dual plug beam splitter
  • Observation tube
  • Adapter for 1/2″ digital camera

Enquire Now

By submitting your enquiry you agree to our privacy policy and consent to further correspondence from Sigmacon by email.

Contact

Stanmore

info@sigmacon.co.uk

Tel: +44 (0)20 8950 9501

Sigmacon

Privacy Policy

Allowing for less blood loss and maintenance of stone clearance, this study published in the World Journal of Urology found mini PCNL to be the ideal tract for medium sized renal stones. Read more here:
https://t.co/aEeKKBGzZ0

Load More...